[Molecular Imaging Medicinal Chemistry Laboratory] Team Leader:Masaaki Suzuki

- Creating Molecules -

Development of PET molecular probes applicable to animal and human PET studies by pursuing the potentials of chemical biology and advanced synthetic organic chemistry as the axis of molecular science. With the objective of creating highly-functionalized molecular probes for facilitating PET molecular imaging science, we seek to develop the future medicinal chemistry and explore the new methodology in in vivo molecular science with the view of general versatility.


1) Development of new chemical methodologies and key concepts in molecular science for the promotion of PET molecular imaging science

Focusing on the potentials of PET imaging technology applicable to small animals and human clinical studies, we are engaged in developing the new labeling methodology of disease-associated proteins and the highly-efficient synthetic methodology, necessary for advancing medicinal chemistry for molecular probe development, and furthermore realizing rapid chemical reactions for introducing 11C and 18F as short-lived positron emission nuclides into carbon frameworks of bioactive organic compounds with the aim of creating PET molecular probes with chemical and metabolic stability at radiolabeling positions.

2) Development of disease-associated PET molecular probes

For demonstrating our methodologies, we are evolving the design and synthesis of PET molecular probes and exploring key compounds associated with new biological functions or important diseases such as cancers. Some of our present research activities are exemplified by development of 4 types of Pd0-mediated rapid C-[11C]methylations on arene, alkene, alkyne, and alkane, realization of 11C-labeled 15R-TIC methyl ester as a prostacyclin receptor ligand with specific neuroprotective effect for central nerves system, development of highly-efficient 11C-labeling of thymidine analogues for canner imaging, synthesis of 11C-labeled retinoic acids with anticancer effects, synthesis of 11C-labeled iloprost methyl ester with potent vasodilatory effects, and development of other rapid C-[11C]methylations via enolate intermediates representative by realization of 11C-labeled Ketoprofen methyl ester.

June 11,2010
Projecting pain relief
Radioactively labeled drugs can track inflammation in the brain


[Contact information for research-related enquiries]
Masaaki Suzuki TEL 078-304-7130 Mail 
[Contact information for non-research-related enquiries]
Yasuko Kawai TEL 078-304-7130 Mail